Group One Trading, L.P. Aldeyra Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 132,987 shares of ALDX stock, worth $759,355. This represents 0.02% of its overall portfolio holdings.
Number of Shares
132,987
Previous 164,411
19.11%
Holding current value
$759,355
Previous $945,000
46.14%
% of portfolio
0.02%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding ALDX
# of Institutions
134Shares Held
34.9MCall Options Held
244KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$31.3 Million14.27% of portfolio
-
Perceptive Advisors LLC New York, NY4.05MShares$23.1 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$20.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$20 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT2.05MShares$11.7 Million1.29% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $333M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...